Immune Checkpoint Inhibitors in Preexisting Autoimmune Disease: Comment on the Article by Tison Et Al

Wen-hui Xie,Zhuo-li Zhang
DOI: https://doi.org/10.1002/art.41137
2020-01-01
Arthritis & Rheumatology
Abstract:Arthritis & RheumatologyVolume 72, Issue 3 p. 506-506 Letters Immune Checkpoint Inhibitors in Preexisting Autoimmune Disease: Comment on the Article by Tison et al Wen-hui Xie, Wen-hui Xie orcid.org/0000-0002-3881-0266 Peking University First Hospital, Beijing, ChinaSearch for more papers by this authorZhuo-li Zhang, Zhuo-li Zhang Peking University First Hospital, Beijing, ChinaSearch for more papers by this author Wen-hui Xie, Wen-hui Xie orcid.org/0000-0002-3881-0266 Peking University First Hospital, Beijing, ChinaSearch for more papers by this authorZhuo-li Zhang, Zhuo-li Zhang Peking University First Hospital, Beijing, ChinaSearch for more papers by this author First published: 14 October 2019 https://doi.org/10.1002/art.41137Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume72, Issue3March 2020Pages 506-506 RelatedInformation
What problem does this paper attempt to address?